PASTEUR Act of 2026

Summary

Creates a new Public Health Service authority aimed at ensuring the availability of antimicrobials by encouraging research and development, improving market access, promoting appropriate use and stewardship, maintaining medical care standards, strengthening health system preparedness, and supporting U.S. defense and military readiness. The bill adds a new provision titled "Developing antimicrobial innovations" to Title III of the Public Health Service Act, but the actual text of that new provision and any program details, funding, timelines, or requirements are not included in the provided excerpt, so specific implementation effects are unknown.

• Adds a new provision to the Public Health Service Act focused on developing antimicrobial innovations.
• Specifies broad purposes: stimulate R&D, improve market access, ensure appropriate use, support medical care standards, advance preparedness, and aid defense readiness.
• Establishes an official short title for the Act.
• The inserted provision text is not provided, so program details, funding, deadlines, and requirements are unknown.
• Likely to affect federal public health authorities and programs, researchers, manufacturers, hospitals, and patients who rely on antimicrobials.
• Does not, in the excerpt, repeal or alter existing Title III language beyond appending the new provision.
• Because details are missing, the measure primarily creates enabling authority rather than specifying concrete spending or regulatory changes in the provided text.